United States · FDA National Drug Code directory
Abecma
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59572-515_4adbd9af-42bb-4e51-86fc-b06ccd213b43
- Product NDC
- 59572-515
- Form
- SUSPENSION
- Composition / generic term
- idecabtagene vicleucel
- Labeler
- Celgene Corporation
- Marketing category
- BLA
- Marketing start / end (source format)
- 20210326
- Source listing expiry
- 20271231
Source-listed ingredients
- IDECABTAGENE VICLEUCEL — 300000000 1/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SUSPENSION in 1 BAG (59572-515-01) · 59572-515-01
- 1 SUSPENSION in 1 BAG (59572-515-02) · 59572-515-02
- 1 SUSPENSION in 1 BAG (59572-515-03) · 59572-515-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →